PR Newswire Clinical TrialsOriginal article
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
EarningsLeqembiNeutral
AI Analysis
Summary
BioArctic's partner Eisai reported Leqembi Q2 2026 sales of 29.3 billion yen in conjunction with Biogen's quarterly earnings report.
Financial Highlights
Revenue
29.3 billion yen
Outcome Details
Q2 2026 revenue reported
Importance:5/10
Sentiment:
0.20
CommercialRevenuePartnershipLeqembi
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 29, 2026 10:30 AM